Myeloma Minute: Takeaways from ASH 2019


| INNOVATION | Latest Research


Takeaways from ASH 2019

The IMF team just returned from a busy and exciting meeting of the American Society of Hematology (ASH) in Orlando. In his post-ASH wrap-up blog, IMF Chairman Dr. Brian G.M. Durie reports on the key research takeaways. They include: a consensus on high-risk smoldering myeloma classification, excitement over the value of mass spectrometry testing, and speculation that a four-drug cocktail (a “quadruplet”) could be the new standard of care in the frontline setting.


| INNOVATION | Livestream Replay


Watch a Replay of Approaches to Achieve the Best Possible Outcomes in Myeloma

At the 2019 American Society of Hematology annual conference, international experts gathered to discuss practice-changing data and optimal management of patients with myeloma. The expert panel includes Drs. Brian G.M. Durie, Shaji Kumar, Thomas G. Martin, Philippe Moreau, S. Vincent Rajkumar, and Jesús F. San-Miguel. In case you missed it, you can catch a replay at the link below.


| INSPIRATION | Holiday Shopping




When You Shop Amazon Smile, Choose the IMF as Your Charity
You Made a Difference

You are probably already busy doing your holiday shopping. Why not select the International Myeloma Foundation as your preferred charity from This way every time you shop, Amazon gives to the IMF. It is all at no added cost to you—the gift of choice!

Last week, you all came together for #GivingTuesday and funded the IMF’s mission of improving the quality of lives of multiple myeloma patients everywhere, while working toward prevention and a cure. We are overjoyed to announced that we have exceeded our goal of $35K, with more than $40K in donations. YOU MADE A DIFFERENCE. If you were not able to give, you have until Dec. 31, 2019, to donate to the IMF and still receive a tax deduction on your 2019 tax returns.



| INNOVATION | IMWG Conference Series


Watch a Replay of the IMWG Conference Series

The IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" was recorded live from ASH this past Monday. IMF Chairman Dr. Brian G.M. Durie, Dr. María V. Mateos, and IMF Chief Medical Officer Dr. Joseph Mikhael debated and discussed the latest news and trends in the treatment of multiple myeloma. In case you missed it, watch a replay at the link below.


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



Search the Myeloma Matrix 2.0

Join the conversation about myeloma on the Smart Patients Message Board

Clinical Trial Fact Sheets

OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

December 17, 2019
Scrumptious Cookie Fundraiser

Amy’s Opal Jewelry Fundraiser

January 9, 2020
Best of ASH 2019

January 10, 2020
Magical Miles for Myeloma
Walt Disney World - Orlando

March 13-14, 2020
IMF Patient & Family Seminar
Boca Raton, FL

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Bristol-Myers Squibb, Genentech, and Takeda Oncology

We also thank individuals like you for your continued support!

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.